Home / Inspections / 1316070

FDA Inspection 1316070 — Pacira Pharmaceuticals, Inc.

Pacira Pharmaceuticals, Inc. — FEI 3002783962

The FDA completed an inspection of Pacira Pharmaceuticals, Inc. on March 25, 2026 in San Diego, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 25, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
San Diego, CA (United States)

Facility

Other inspections at this facility

  • 1203460 (VAI Wed Apr 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1102447 (NAI Fri Sep 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1047746 (VAI Thu Mar 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 935306 (VAI Wed Jul 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 865612 (VAI Mon Feb 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources